Table 1 Pathways altered with aging. Pathways were grouped into categories, and B-H multiple testing p-values assigned.
From: Distal lung epithelial progenitor cell function declines with age
Class | Category of pathways altered | B-H p-values |
|---|---|---|
Diseases & disorders | Connective tissue disorders | 0.005-0.007 |
Immunological disease | 0.005-0.009 | |
Organismal injury & abnormalities | 0.005-0.009 | |
Respiratory disease | 0.005-0.010 | |
Cancer | 0.005-0.010 | |
Developmental disorder | 0.005-0.010 | |
Metabolic disease | 0.005-0.010 | |
Haematological disease | 0.005-0.010 | |
Skeletal & muscular disorders | 0.005-0.010 | |
Neurological disease | 0.005-0.010 | |
Endocrine system disorders | 0.005-0.010 | |
Hereditary disorder | 0.005-0.010 | |
Renal and urological disease | 0.005-0.010 | |
Development & function | Organ morphology | 0.005-0.010 |
Organismal development | 0.005-0.010 | |
Haematological system development & function | 0.005-0.010 | |
Nervous system development & function | 0.005-0.010 | |
Molecular & cellular mechanisms | Cellular assembly & organisation | 0.005-0.008 |
Cellular compromise | 0.005-0.008 | |
Cell death & survival | 0.005-0.010 | |
Cellular growth & proliferation | 0.005-0.010 | |
Cell cycle | 0.005-0.010 | |
Cell-to-cell signalling & interaction | 0.005-0.010 | |
Cellular movement | 0.005-0.010 | |
Cellular function & maintenance | 0.005-0.010 |
